In hematologic cancers, studies have demonstrated Gal-9’s involvement in the pathophysiology of various leukemias, with elevated levels correlating with more severe disease, which aligns with our findings [28,29]. The gene discussed is LGALS9; the disease is hematopoietic and lymphoid cell neoplasm.